Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02416908 · COMPLETED
Trial details
- NCT number
- NCT02416908
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-16
- Primary completion
- 2019-06-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.